Cargando…
Is the high-risk strategy to prevent cardiovascular disease equitable? A pharmacoepidemiological cohort study
BACKGROUND: Statins are increasingly prescribed to prevent cardiovascular disease (CVD) in asymptomatic individuals. Yet, it is unknown whether those at higher CVD risk – i.e. individuals in lower socio-economic position (SEP) – are adequately reached by this high-risk strategy. We aimed to examine...
Autores principales: | Wallach-Kildemoes, Helle, Diderichsen, Finn, Krasnik, Allan, Lange, Theis, Andersen, Morten |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3444315/ https://www.ncbi.nlm.nih.gov/pubmed/22863326 http://dx.doi.org/10.1186/1471-2458-12-610 |
Ejemplares similares
-
High Risk versus Proportional Benefit: Modelling Equitable Strategies in Cardiovascular Prevention
por: Marchant, Ivanny, et al.
Publicado: (2015) -
Artificial Intelligence in Pharmacoepidemiology: A Systematic Review. Part 2–Comparison of the Performance of Artificial Intelligence and Traditional Pharmacoepidemiological Techniques
por: Sessa, Maurizio, et al.
Publicado: (2021) -
Childhood socioeconomic position, young adult intelligence and fillings of prescribed medicine for prevention of cardiovascular disease in middle-aged men
por: Kriegbaum, Margit, et al.
Publicado: (2014) -
Methods for time‐varying exposure related problems in pharmacoepidemiology: An overview
por: Pazzagli, Laura, et al.
Publicado: (2017) -
Pattern of statin use changes following media coverage of its side effects
por: Kriegbaum, Margit, et al.
Publicado: (2017)